MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis

NCT06592352 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Cognitive Impairment

Interventions

DRUG: Modafinil Generis 100 mg

Sponsor

Clinical Academic Center (2CA-Braga)